{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:03:49Z","timestamp":1750478629135,"version":"3.41.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The current study aimed to examine how smooth muscle contractile properties and expression of functional proteins in the urethra and prostate are affected in an animal model of chronic prostatitis\/chronic pelvic pain syndrome (CPPS). Thirty-two male Sprague-Dawley rats received an intraprostatic injection with saline or zymosan, serving as control and a model for CPPS, respectively. Two weeks later, the urethra and dorsal prostate were excised and studied functionally in organ baths. Following this, protein expression and urethral inflammation was examined immunohistochemically. Neither prostate nor urethra showed any significant changes in contractility compared to the control group, despite a tendency for increased cholinergic contractile responses in the CPPS urethra. Induction of CPPS led to an increased expression of muscarinic M3 receptors in the urethra. In the prostate, there were no significant differences in protein expression. HE staining showed no signs of inflammation in the urethra in either group. Previous studies have shown that CPPS can alter bladder contractility. Currently, CPPS did not affect contractile responses in neither prostate nor urethra. These findings are consistent with the theory of prostate-to-bladder cross-organ sensitization. Future studies exploring this may be of great relevance in the development of new treatment options for CPPS.<\/jats:p>","DOI":"10.1038\/s41598-025-06531-7","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T14:17:33Z","timestamp":1750429053000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Induction of chronic prostatitis does not alter the innate contractile properties of the prostate or urethra in rats"],"prefix":"10.1038","volume":"15","author":[{"given":"Ozgu","family":"Aydogdu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwenaelle","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrik","family":"Aronsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2527-4713","authenticated-orcid":false,"given":"Michael","family":"Winder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"6531_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/pros.24101","volume":"81","author":"O Aydogdu","year":"2021","unstructured":"Aydogdu, O., Gocun, P. U., Aronsson, P., Carlsson, T. & Winder, M. Prostate-to-bladder cross-sensitization in a model of zymosan-induced chronic pelvic pain syndrome in rats. Prostate 81, 252\u2013260. https:\/\/doi.org\/10.1002\/pros.24101 (2021).","journal-title":"Prostate"},{"key":"6531_CR2","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.juro.2016.03.077","volume":"196","author":"ES Schwartz","year":"2016","unstructured":"Schwartz, E. S. et al. Chronic prostatitis induces bladder hypersensitivity and sensitizes bladder afferents in the mouse. J. Urol. 196, 892\u2013901. https:\/\/doi.org\/10.1016\/j.juro.2016.03.077 (2016).","journal-title":"J. Urol."},{"key":"6531_CR3","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1113\/JP277452","volume":"597","author":"Y Funahashi","year":"2019","unstructured":"Funahashi, Y. et al. Bladder overactivity and afferent hyperexcitability induced by prostate-to-bladder cross-sensitization in rats with prostatic inflammation. J. Physiol. 597, 2063\u20132078. https:\/\/doi.org\/10.1113\/JP277452 (2019).","journal-title":"J. Physiol."},{"key":"6531_CR4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/pcan.2016.8","volume":"19","author":"AS Polackwich","year":"2016","unstructured":"Polackwich, A. S. & Shoskes, D. A. Chronic prostatitis\/chronic pelvic pain syndrome: a review of evaluation and therapy. Prostate Cancer Prostatic Dis. 19, 132\u2013138. https:\/\/doi.org\/10.1038\/pcan.2016.8 (2016).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"6531_CR5","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1001\/jama.282.3.236","volume":"282","author":"JN Krieger","year":"1999","unstructured":"Krieger, J. N., Nyberg, L. Jr & Nickel, J. C. NIH consensus definition and classification of prostatitis. Jama 282, 236\u2013237. https:\/\/doi.org\/10.1001\/jama.282.3.236 (1999).","journal-title":"Jama"},{"key":"6531_CR6","doi-asserted-by":"publisher","unstructured":"Aydogdu, O. et al. Treatment with the soluble guanylate cyclase activator BAY 60-2770 normalizes bladder function in an in vivo rat model of chronic prostatitis. Eur. J. Pharmacol. 175052. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175052 (2022).","DOI":"10.1016\/j.ejphar.2022.175052"},{"key":"6531_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12894-021-00882-9","volume":"21","author":"O Aydogdu","year":"2021","unstructured":"Aydogdu, O., Gocun, P. U., Aronsson, P., Carlsson, T. & Winder, M. Cross-organ sensitization between the prostate and bladder in an experimental rat model of lipopolysaccharide (LPS)-induced chronic pelvic pain syndrome. BMC Urol. 21, 113. https:\/\/doi.org\/10.1186\/s12894-021-00882-9 (2021).","journal-title":"BMC Urol."},{"key":"6531_CR8","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1053\/j.gastro.2005.03.008","volume":"128","author":"MA Pezzone","year":"2005","unstructured":"Pezzone, M. A., Liang, R. & Fraser, M. O. A model of neural cross-talk and irritation in the pelvis: implications for the overlap of chronic pelvic pain disorders. Gastroenterology 128, 1953\u20131964. https:\/\/doi.org\/10.1053\/j.gastro.2005.03.008 (2005).","journal-title":"Gastroenterology"},{"key":"6531_CR9","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.neuroscience.2007.07.053","volume":"149","author":"AP Malykhina","year":"2007","unstructured":"Malykhina, A. P. Neural mechanisms of pelvic organ cross-sensitization. Neuroscience 149, 660\u2013672. https:\/\/doi.org\/10.1016\/j.neuroscience.2007.07.053 (2007).","journal-title":"Neuroscience"},{"key":"6531_CR10","doi-asserted-by":"publisher","unstructured":"Aydogdu, O. et al. Treatment with the soluble guanylate cyclase activator BAY 60-2770 restores in vitro bladder contractile responses in a rat model of chronic prostatitis. Continence 4 https:\/\/doi.org\/10.1016\/j.cont.2022.100520 (2022).","DOI":"10.1016\/j.cont.2022.100520"},{"key":"6531_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/nau.20194","volume":"25","author":"RD Walters","year":"2006","unstructured":"Walters, R. D., McMurray, G. & Brading, A. F. Comparison of the urethral properties of the female guinea pig and rat. Neurourol. Urodyn. 25, 62\u201369. https:\/\/doi.org\/10.1002\/nau.20194 (2006).","journal-title":"Neurourol. Urodyn."},{"key":"6531_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4103\/tcmj.tcmj_221_22","volume":"35","author":"PC Hsieh","year":"2023","unstructured":"Hsieh, P. C., Chang, S. J., Chang, H. H. & Yang, S. S. The differences in the adrenergic receptors of proximal urethra between sexes. Tzu Chi Med. J. 35, 253\u2013259. https:\/\/doi.org\/10.4103\/tcmj.tcmj_221_22 (2023).","journal-title":"Tzu Chi Med. J."},{"key":"6531_CR13","doi-asserted-by":"publisher","unstructured":"Andersson, K. E. Muscarinic acetylcholine receptors in the urinary tract. Handb. Exp. Pharmacol. 319\u2013344. https:\/\/doi.org\/10.1007\/978-3-642-16499-6_16 (2011).","DOI":"10.1007\/978-3-642-16499-6_16"},{"key":"6531_CR14","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0022-5347(05)64913-0","volume":"168","author":"T Yamanishi","year":"2002","unstructured":"Yamanishi, T., Chapple, C. R., Yasuda, K., Yoshida, K. & Chess-Williams, R. The role of M2 muscarinic receptor subtypes mediating contraction of the circular and longitudinal smooth muscle of the pig proximal urethra. J. Urol. 168, 308\u2013314 (2002).","journal-title":"J. Urol."},{"key":"6531_CR15","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1113\/JP285583","volume":"602","author":"H Hashitani","year":"2024","unstructured":"Hashitani, H., Mitsui, R., Hirai, Y., Tanaka, H. & Miwa-Nishimura, K. Nitrergic Inhibition of sympathetic arteriolar constrictions in the female rodent urethra. J. Physiol. 602, 2199\u20132226. https:\/\/doi.org\/10.1113\/JP285583 (2024).","journal-title":"J. Physiol."},{"key":"6531_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0165-1838(94)00160-l","volume":"52","author":"K Persson","year":"1995","unstructured":"Persson, K., Alm, P., Johansson, K., Larsson, B. & Andersson, K. E. Co-existence of nitrergic, peptidergic and acetylcholine esterase-positive nerves in the pig lower urinary tract. J. Auton. Nerv. Syst. 52, 225\u2013236. https:\/\/doi.org\/10.1016\/0165-1838(94)00160-l (1995).","journal-title":"J. Auton. Nerv. Syst."},{"key":"6531_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3109\/00365598309180158","volume":"17","author":"J Ekstrom","year":"1983","unstructured":"Ekstrom, J. & Elmer, M. Supersensitivity in the isolated urethra of the rat following chemical sympathectomy. Scand. J. Urol. Nephrol. 17, 145\u2013148. https:\/\/doi.org\/10.3109\/00365598309180158 (1983).","journal-title":"Scand. J. Urol. Nephrol."},{"key":"6531_CR18","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1474-8673.1994.tb00618.x","volume":"14","author":"R Chess-Williams","year":"1994","unstructured":"Chess-Williams, R., Aston, N. & Couldwell, C. Alpha 1A-adrenoceptor subtype mediates contraction of the rat urethra. J. Auton. Pharmacol. 14, 375\u2013381. https:\/\/doi.org\/10.1111\/j.1474-8673.1994.tb00618.x (1994).","journal-title":"J. Auton. Pharmacol."},{"key":"6531_CR19","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/jcmm.13345","volume":"22","author":"P Chen","year":"2018","unstructured":"Chen, P. et al. The expression and functional activities of smooth muscle myosin and non-muscle myosin isoforms in rat prostate. J. Cell. Mol. Med. 22, 576\u2013588. https:\/\/doi.org\/10.1111\/jcmm.13345 (2018).","journal-title":"J. Cell. Mol. Med."},{"key":"6531_CR20","doi-asserted-by":"publisher","first-page":"704e709","DOI":"10.1016\/j.urology.2014.12.002","volume":"85","author":"D Wang","year":"2015","unstructured":"Wang, D. et al. Effects of the 5alpha-reductase inhibitor dutasteride on rat prostate alpha1A-adrenergic receptor and its mediated contractility. Urology 85, 704e709\u2013704e714. https:\/\/doi.org\/10.1016\/j.urology.2014.12.002 (2015).","journal-title":"Urology"},{"key":"6531_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/iju.13018","volume":"23","author":"BR Choi","year":"2016","unstructured":"Choi, B. R. et al. Effect of 4-chloro-7-trifluoromethyl-10H-benzo[4,5]furo[3,2-b]indole-1-carboxylic acid on the intraurethral pressure in a rat model of benign prostatic hyperplasia. Int. J. Urol. 23, 259\u2013265. https:\/\/doi.org\/10.1111\/iju.13018 (2016).","journal-title":"Int. J. Urol."},{"key":"6531_CR22","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1476-5381.2011.01332.x","volume":"163","author":"S Ventura","year":"2011","unstructured":"Ventura, S. et al. Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH). Br. J. Pharmacol. 163, 891\u2013907. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01332.x (2011).","journal-title":"Br. J. Pharmacol."},{"key":"6531_CR23","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S0022-3565(25)19979-5","volume":"252","author":"RN Willette","year":"1990","unstructured":"Willette, R. N., Sauermelch, C. F. & Hieble, J. P. Role of alpha-1 and alpha-2 adrenoceptors in the sympathetic control of the proximal urethra. J. Pharmacol. Exp. Ther. 252, 706\u2013710 (1990).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"6531_CR24","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/j.juro.2012.01.072","volume":"187","author":"A Dey","year":"2012","unstructured":"Dey, A., Lang, R. J. & Exintaris, B. Nitric oxide signaling pathways involved in the Inhibition of spontaneous activity in the guinea pig prostate. J. Urol. 187, 2254\u20132260. https:\/\/doi.org\/10.1016\/j.juro.2012.01.072 (2012).","journal-title":"J. Urol."},{"key":"6531_CR25","doi-asserted-by":"publisher","unstructured":"Kang, K. K. et al. Effects of phosphodiesterase type 5 inhibitor on the contractility of prostate tissues and urethral pressure responses in a rat model of benign prostate hyperplasia. Int. J. Urol. 14, 946\u2013951 https:\/\/doi.org\/10.1111\/j.1442-2042.2007.01874.x (2007).","DOI":"10.1111\/j.1442-2042.2007.01874.x"},{"key":"6531_CR26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000277604","volume":"84","author":"JG Lee","year":"2010","unstructured":"Lee, J. G. et al. Relaxation effect of phosphodiesterase-5 inhibitor on the animal bladder and prostatic urethra: in vitro and in vivo study. Urol. Int. 84, 231\u2013235. https:\/\/doi.org\/10.1159\/000277604 (2010).","journal-title":"Urol. Int."},{"key":"6531_CR27","doi-asserted-by":"publisher","first-page":"1249560","DOI":"10.3389\/fphys.2023.1249560","volume":"14","author":"P Aronsson","year":"2023","unstructured":"Aronsson, P. et al. Soluble guanylate cyclase mediates the relaxation of healthy and inflamed bladder smooth muscle by aqueous nitric oxide. Front. Physiol. 14, 1249560. https:\/\/doi.org\/10.3389\/fphys.2023.1249560 (2023).","journal-title":"Front. Physiol."},{"key":"6531_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0031-6997(25)06663-3","volume":"43","author":"S Moncada","year":"1991","unstructured":"Moncada, S., Palmer, R. M. & Higgs, E. A. Nitric oxide: physiology, pathophysiology, and Pharmacology. Pharmacol. Rev. 43, 109\u2013142 (1991).","journal-title":"Pharmacol. Rev."},{"key":"6531_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/path.5859","author":"IV Zabbarova","year":"2021","unstructured":"Zabbarova, I. V. et al. Benign prostatic hyperplasia\/obstruction ameliorated using a soluble guanylate cyclase activator. J. Pathol. https:\/\/doi.org\/10.1002\/path.5859 (2021).","journal-title":"J. Pathol."},{"key":"6531_CR30","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/nau.22435","volume":"33","author":"P Aronsson","year":"2014","unstructured":"Aronsson, P., Carlsson, T., Winder, M. & Tobin, G. A novel in situ urinary bladder model for studying afferent and efferent mechanisms in the micturition reflex in the rat. Neurourol. Urodyn. 33, 550\u2013557. https:\/\/doi.org\/10.1002\/nau.22435 (2014).","journal-title":"Neurourol. Urodyn."},{"key":"6531_CR31","first-page":"209","volume":"63","author":"R Vesela","year":"2012","unstructured":"Vesela, R., Aronsson, P., Andersson, M., Wsol, V. & Tobin, G. The potential of non-adrenergic, non-cholinergic targets in the treatment of interstitial cystitis\/painful bladder syndrome. J. Physiol. Pharmacol. 63, 209\u2013216 (2012).","journal-title":"J. Physiol. Pharmacol."},{"key":"6531_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/nau.22562","author":"P Aronsson","year":"2014","unstructured":"Aronsson, P., Carlsson, T., Winder, M. & Tobin, G. Cyclophosphamide-induced alterations of the micturition reflex in a novel in situ urinary bladder model in the anesthetized rat. Neurourol. Urodyn. https:\/\/doi.org\/10.1002\/nau.22562 (2014).","journal-title":"Neurourol. Urodyn."},{"key":"6531_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11302-013-9395-y","volume":"10","author":"G Burnstock","year":"2014","unstructured":"Burnstock, G. Purinergic signalling in the urinary tract in health and disease. Purinergic Signal. 10, 103\u2013155. https:\/\/doi.org\/10.1007\/s11302-013-9395-y (2014).","journal-title":"Purinergic Signal."},{"key":"6531_CR34","doi-asserted-by":"publisher","unstructured":"Aronsson, P. et al. Inhibition of nitric oxide synthase prevents muscarinic and purinergic functional changes and development of cyclophosphamide-induced cystitis in the rat. Biomed. Res. Int. 359179 https:\/\/doi.org\/10.1155\/2014\/359179 (2014).","DOI":"10.1155\/2014\/359179"},{"key":"6531_CR35","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00210-020-02044-4","volume":"394","author":"A Spek","year":"2021","unstructured":"Spek, A. et al. Purinergic smooth muscle contractions in the human prostate: Estimation of relevance and characterization of different agonists. Naunyn Schmied. Arch. Pharmacol. 394, 1113\u20131131. https:\/\/doi.org\/10.1007\/s00210-020-02044-4 (2021).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"6531_CR36","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/sj.bjp.0705167","volume":"138","author":"S Ventura","year":"2003","unstructured":"Ventura, S., Dewalagama, R. K. & Lau, L. C. Adenosine 5\u2019-triphosphate (ATP) is an excitatory cotransmitter with noradrenaline to the smooth muscle of the rat prostate gland. Br. J. Pharmacol. 138, 1277\u20131284. https:\/\/doi.org\/10.1038\/sj.bjp.0705167 (2003).","journal-title":"Br. J. Pharmacol."},{"key":"6531_CR37","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1152\/physrev.00038.2003","volume":"84","author":"KE Andersson","year":"2004","unstructured":"Andersson, K. E. & Arner, A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol. Rev. 84, 935\u2013986 (2004).","journal-title":"Physiol. Rev."},{"key":"6531_CR38","doi-asserted-by":"publisher","unstructured":"Winder, M., Tobin, G., Zupancic, D. & Romih, R. Signalling molecules in the urothelium. Biomed. Res. Int. 2014 (297295). https:\/\/doi.org\/10.1155\/2014\/297295 (2014).","DOI":"10.1155\/2014\/297295"},{"key":"6531_CR39","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1152\/physrev.00043.2006","volume":"87","author":"G Burnstock","year":"2007","unstructured":"Burnstock, G. Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev. 87, 659\u2013797. https:\/\/doi.org\/10.1152\/physrev.00043.2006 (2007).","journal-title":"Physiol. Rev."},{"key":"6531_CR40","doi-asserted-by":"publisher","first-page":"e100115","DOI":"10.1136\/bmjos-2020-100115","volume":"4","author":"Percie du Sert","year":"2020","unstructured":"Percie du Sert. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. BMJ Open Sci. 4, e100115. https:\/\/doi.org\/10.1136\/bmjos-2020-100115 (2020).","journal-title":"BMJ Open. Sci."},{"issue":"Pt 1","key":"6531_CR41","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1469-7793.1999.271aa.x","volume":"516","author":"U Simonsen","year":"1999","unstructured":"Simonsen, U., Wadsworth, R. M., Buus, N. H. & Mulvany, M. J. In vitro simultaneous measurements of relaxation and nitric oxide concentration in rat superior mesenteric artery. J. Physiol. 516 (Pt 1), 271\u2013282. https:\/\/doi.org\/10.1111\/j.1469-7793.1999.271aa.x (1999).","journal-title":"J. Physiol."},{"key":"6531_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-3801-8_1","volume":"1458","author":"H Mori","year":"2016","unstructured":"Mori, H. & Cardiff, R. D. Methods of immunohistochemistry and immunofluorescence: converting invisible to visible. Methods Mol. Biol. 1458, 1\u201312. https:\/\/doi.org\/10.1007\/978-1-4939-3801-8_1 (2016).","journal-title":"Methods Mol. Biol."},{"key":"6531_CR43","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/bph.14153","volume":"175","author":"MJ Curtis","year":"2018","unstructured":"Curtis, M. J. et al. Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers. Br. J. Pharmacol. 175, 987\u2013993. https:\/\/doi.org\/10.1111\/bph.14153 (2018).","journal-title":"Br. J. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06531-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06531-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06531-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T14:17:34Z","timestamp":1750429054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06531-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6531"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-06531-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20226"}}